SEC Form 4 · accession 0001213900-26-082533
Nano-X Imaging Ltd. · NNOX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Noga Kainan
Director
Period of report
Jul 28, 2026
Accepted (ET)
Jul 29, 2026 · 7:35 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001795251
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jul 28, 2026 | P | 33,000 | $0.90 | A | 40,792 | D | |
| Ordinary SharesF1 | holding | — | — | — | 794 | I | By: I.B.L. Business Consulting Ltd, a company wholly owned by the reporting person | |
| Ordinary SharesF1,F2 | holding | — | — | — | 17,544 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy ordinary shares)F1,F3 | $64.61 | holding | — | — | — | — | Feb 9, 2031 | Ordinary Shares | 12,505 | 12,505 | D |
| Stock Option (right to buy ordinary shares)F1,F4 | $17.63 | holding | — | — | — | — | Dec 28, 2032 | Ordinary Shares | 50,000 | 50,000 | D |
| Stock Option (right to buy ordinary shares)F1,F5 | $11.52 | holding | — | — | — | — | Dec 31, 2033 | Ordinary Shares | 10,000 | 10,000 | D |
Explanation of responses
- F1There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F2The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on December 10, 2025 and that vest in twelve equal monthly installments such that they will be fully vested upon the one-year anniversary of the grant date.
- F3The options reported in this row were granted to the Reporting Person by the Issuer on February 9, 2021 and are fully vested and exercisable as of the date of this report.
- F4The options reported in this row were granted to the Reporting Person by the Issuer on December 28, 2022 and are fully vested and exercisable as of the date of this report.
- F5The options reported in this row were granted to the Reporting Person by the Issuer on December 31, 2023 and vest and become exercisable in 16 equal installments of 6.25% each on each three-month anniversary of the date of approval of the grant by the Issuer's Board of Directors (i.e., August 14, 2023), such that all options reported in this row will be exercisable on the four-year anniversary of that grant approval date (August 14, 2027).
Remarks
Exhibit 24.1 - Power of Attorney